European Commission warns against COVID-19 booster shots
The EC holds that there is not enough information available about potential risks linked to giving patients a third dose.
BRUSSELS (LifeSiteNews)—In a statement to the mainstream news agency Reuters, the European Commission (EC) has warned EU countries against unilaterally rolling out additional boosters for the COVID experimental “vaccines.”
The EC holds that there is not enough information available about potential risks linked to giving patients a third dose, as many European countries are already planning to do.
An extra booster shot is being touted in many countries as capable of substantially raising the immunity of the vaccinated, even against new variants, now that it has become abundantly clear that so-called “fully vaccinated” people are not at all fully protected from contamination and can also spread the coronavirus responsible for COVID-19.
The European Medicines Agency is at present not prepared to authorize the “third shot,” which means that countries that recommend giving an extra shot to so-called “fully vaccinated” people must face the consequences alone if any problems should arise.
Reuters quoted the European Commission, the EU’s executive body, as having said: “Booster doses are currently not part of the marketing authorization of COVID-19 vaccines and have not yet been subject to a scientific assessment by EMA in the absence of sufficient data.”
The Commission’s statement added that “the responsibility to decide to include boosters in their vaccination campaign remains with the Member States (…) As long as the booster doses are not part of the marketing authorization, companies’ liability is modified.”
In other words, neither the EU nor Pfizer, Moderna, Johnson & Johnson, and AstraZeneca, the four labs that have gained exclusive approval for their “vaccines” on the territory of the EU, would be considered responsible for any adverse effect that would normally allow victims to seek compensation.
At present, who takes what responsibility for adverse effects of the experimental Spike protein injections is not very clear. European Union rules apply when adverse effects are deemed to be “unexpected” and related either to the product’s general characteristics or to the way it was manufactured. Member countries are expected to manage compensation according to EU rules while the labs involved have negotiated specific clauses with the EU that remain confidential for the most part.
The issue raised by the European Commission is that of “unexpected” adverse effects that would be proved to be linked to the administration of an extra booster shot. Such boosters are already being recommended by France, Austria, Belgium, Hungary, Liechtenstein, Lithuania, Luxembourg, and Slovenia in order to counter – they say – dwindling “protection” as the SARS-CoV-2 Delta variant continues to replace the coronavirus the approved “vaccines” were designed to combat.
Germany and 13 other EU countries are also considering offering third doses to their “fragile” citizens – if not imposing them, for it appears more and more probable that the definition of “full vaccination” will be modified as regards sanitary passes now required in several EU countries for many daily activities.
The Commission is in effect telling those who will go ahead with the third dose – as France intends to do with its elderly population as of September 13, as well as with patients with comorbidities – that governments themselves would likely be obliged to bear the brunt of any successful lawsuits linked to such serious side-effects. READ MORE>>>>HERE